Sara Tartof to Vaccines
This is a "connection" page, showing publications Sara Tartof has written about Vaccines.
Connection Strength
2.857
-
Increased vaccine sensitivity of an emerging SARS-CoV-2 variant. Nat Commun. 2023 06 29; 14(1):3854.
Score: 0.671
-
Effectiveness Associated With BNT162b2 Vaccine Against Emergency Department and Urgent Care Encounters for Delta and Omicron SARS-CoV-2 Infection Among Adolescents Aged 12 to 17 Years. JAMA Netw Open. 2022 08 01; 5(8):e2225162.
Score: 0.630
-
Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants. Lancet Respir Med. 2022 07; 10(7):e61-e62.
Score: 0.619
-
Inpatient admission for febrile seizure and subsequent outcomes do not differ in children with vaccine-associated versus non-vaccine associated febrile seizures. Vaccine. 2014 Nov 12; 32(48):6408-14.
Score: 0.366
-
Exploring the risk factors for vaccine-associated and non-vaccine associated febrile seizures in a large pediatric cohort. Vaccine. 2014 May 07; 32(22):2574-81.
Score: 0.353
-
Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project. Vaccine. 2019 05 31; 37(25):3296-3302.
Score: 0.126
-
Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol. 2014 Dec; 71(12):1506-13.
Score: 0.093